Figure 1

Survival estimates of the 42 patients, being good (26) or poor (16) prognostic performers at cancer specific survival (A) and overall survival (B) outcomes according to the three-class model6. Survival estimates of the 34 patients, being good (21) or poor (13) prognostic performers at both cancer specific survival (C) and overall survival (D) outcomes.